Looking for a blue chip ASX 200 share or two for your portfolio following the market selloff? Listed below are three that have been given buy ratings recently.
Here’s what you need to know about them:
CSL Limited (ASX: CSL)
The first blue chip ASX 200 share to consider is CSL. It is a leading biotechnology company which is home to the CSL Behring business and the Seqirus business. Combined, these two businesses have a portfolio of life-saving and lucrative therapies and vaccines which are generating billions of dollars in sales each year. In addition, the company invests in the region of 10% to 11% of its sales back into research and development activities every year. This means it is on course to invest around US$1 billion into these activities this year. This ensures that CSL has a pipeline of potentially lucrative products to drive its future growth.
Citi remains positive on CSL. This week the broker put a buy rating and $340.00 price target on its shares.
Goodman Group (ASX: GMG)
Another blue chip ASX 200 share to look at is Goodman Group. It is a leading integrated commercial and industrial property company with a portfolio of warehouses, large scale logistics facilities, and business and office parks. Management notes that it continues to experience strong demand for its properties, which is being driven by increased intensification of use, long-term supply chain requirements, tight supply in urban infill locations and the quality of its assets. In addition, the company has $12.7 billion of development work in progress, which is expected to underpin further solid growth over the coming years.
Citi is also a fan of Goodman. It currently has a buy rating and $28.00 price target on the company’s shares.
SEEK Limited (ASX: SEK)
A final blue chip ASX 200 share to look at is SEEK. It is the dominant force in job listings in the ANZ market and has a number of international operations. While FY 2021 was a difficult year because of the pandemic, SEEK has been bouncing back strongly now the worst is over and hiring is ramping up.
This morning Macquarie retained its outperform rating and $37.00 price target on the company’s shares. It expects SEEK to upgrade its guidance with its half year results.